# Xamiol®Gel in BODY Psoriasis: A One-year Non-interventional Study

> **NCT02636101** · — · COMPLETED · sponsor: **LEO Pharma** · enrollment: 603 (actual)

## Conditions studied

- Psoriasis Vulgaris

## Interventions

- **DRUG:** Calcipotriol/betamethasone dipropionate gel

## Key facts

- **NCT ID:** NCT02636101
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2018-02-15
- **Final completion:** 2018-02-15
- **Target enrollment:** 603 (ACTUAL)
- **Last updated:** 2019-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02636101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02636101, "Xamiol®Gel in BODY Psoriasis: A One-year Non-interventional Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02636101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*